Nasdaq Announces Delisting of Multiple Companies Including NKGen Biotech, Aquaron Acquisition Corp, and Others

Nasdaq announced the delisting of multiple companies' securities due to prolonged trading suspensions.

Quiver AI Summary

The Nasdaq Stock Market announced the delisting of several companies' securities due to their suspension from trading for various periods. Specifically, NKGen Biotech, Inc., Aquaron Acquisition Corp., Bannix Acquisition Corp., Avenue Therapeutics, Inc., WinVest Acquisition Corp., IMAC Holdings, Inc., Lytus Technologies Holdings PTV Ltd., Luokung Technology Corp., Aptose Biosciences, Inc., Virpax Pharmaceuticals, Inc., ClimateRock, Phoenix Motor Inc., AI TRANSPORTATION ACQUISITION CORP, Denali Capital Acquisition Corp., Thunder Power Holdings, Inc., Charles & Colvard Ltd., Yotta Acquisition Corporation, Heramba Electric plc, Cumulus Media Inc., Aimfinity Investment Corp I, Starbox Group Holdings Ltd., Zoomcar Holdings, Inc., ConnectM Technology Solutions, Inc., Investcorp AI Acquisition Corp, Cartesian Growth Corporation II, Hepion Pharmaceuticals, Inc., Accelerate Diagnostics, Inc., Affimed N.V., AppTech Payments Corp., Damon Inc., Zapp Electric Vehicles Group Limited, LeddarTech Holdings Inc., and Marin Software Incorporated will all be delisted following trading suspensions that began between March 5 and June 27, 2025.

Potential Positives

Nasdaq provided transparency about the status of multiple companies' stocks, signaling oversight in maintaining market standards.

Potential Negatives

Several companies, including NKGen Biotech, Inc., have had their securities delisted from the Nasdaq, indicating potential financial instability or regulatory issues.
The suspension and subsequent delisting of these companies' stocks may lead to a loss of investor confidence and damage the companies' reputations.
This mass delisting could suggest broader market issues or concerns regarding the performance and compliance of these companies within the Nasdaq framework.

FAQ

Why is Nasdaq delisting NKGen Biotech, Inc.?

Nasdaq is delisting NKGen Biotech, Inc. due to suspension of its securities since March 5, 2025.

What other companies are being delisted by Nasdaq?

Other delisted companies include Aquaron Acquisition Corp, Bannix Acquisition Corp, Avenue Therapeutics, Inc., and more.

When were the securities of the companies suspended?

The companies' securities were suspended between March 5 and June 27, 2025, prior to delisting announcement.

Where can I find Nasdaq's delisting rules?

Nasdaq's delisting rules are available on their website, specifically under the Nasdaq Rule 5800 Series.

What is the impact of the delisting on shareholders?

Delisting generally impacts shareholders negatively as it restricts trading and may reduce the stock's value.

Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.

$NDAQ Congressional Stock Trading

Members of Congress have traded $NDAQ stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $NDAQ stock by members of Congress over the last 6 months:

REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 05/12.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$NDAQ Insider Trading Activity

$NDAQ insiders have traded $NDAQ stock on the open market 14 times in the past 6 months. Of those trades, 0 have been purchases and 14 have been sales.

Here’s a breakdown of recent trading of $NDAQ stock by insiders over the last 6 months:

BRADLEY J PETERSON (EVP, CIO) has made 0 purchases and 3 sales selling 30,872 shares for an estimated $2,558,260.
SARAH YOUNGWOOD (Executive Vice President) sold 14,959 shares for an estimated $1,102,179
COHEN TAL (President, Market Platforms) sold 8,955 shares for an estimated $749,981
PC NELSON GRIGGS (Pres. Capital Access Platforms) has made 0 purchases and 2 sales selling 8,000 shares for an estimated $664,240.
BRYAN EVERARD SMITH (EVP, CPO) has made 0 purchases and 4 sales selling 7,289 shares for an estimated $569,717.
JEREMY SKULE (EVP, CSO) has made 0 purchases and 3 sales selling 4,211 shares for an estimated $361,237.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$NDAQ Hedge Fund Activity

We have seen 491 institutional investors add shares of $NDAQ stock to their portfolio, and 368 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

BANK OF AMERICA CORP /DE/ added 2,343,908 shares (+48.3%) to their portfolio in Q1 2025, for an estimated $177,808,860
WELLINGTON MANAGEMENT GROUP LLP removed 2,227,056 shares (-6.4%) from their portfolio in Q1 2025, for an estimated $168,944,468
INVESCO LTD. added 1,592,057 shares (+40.8%) to their portfolio in Q1 2025, for an estimated $120,773,444
DIAMOND HILL CAPITAL MANAGEMENT INC removed 1,400,678 shares (-34.0%) from their portfolio in Q1 2025, for an estimated $106,255,433
UBS GROUP AG added 1,082,115 shares (+29.5%) to their portfolio in Q1 2025, for an estimated $82,089,243
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ added 993,553 shares (+5.1%) to their portfolio in Q1 2025, for an estimated $75,370,930
FRANKLIN RESOURCES INC added 935,156 shares (+9.0%) to their portfolio in Q1 2025, for an estimated $70,940,934

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$NDAQ Analyst Ratings

Wall Street analysts have issued reports on $NDAQ in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Barclays issued a "Overweight" rating on 07/10/2025
Raymond James issued a "Outperform" rating on 07/09/2025
Goldman Sachs issued a "Buy" rating on 07/02/2025
Oppenheimer issued a "Outperform" rating on 06/17/2025
Keefe, Bruyette & Woods issued a "Outperform" rating on 04/25/2025
RBC Capital issued a "Outperform" rating on 04/10/2025
Piper Sandler issued a "Overweight" rating on 04/08/2025

To track analyst ratings and price targets for $NDAQ, check out Quiver Quantitative's $NDAQ forecast page.

$NDAQ Price Targets

Multiple analysts have issued price targets for $NDAQ recently. We have seen 12 analysts offer price targets for $NDAQ in the last 6 months, with a median target of $95.0.

Here are some recent targets:

Alex Kramm from UBS set a target price of $95.0 on 07/10/2025
Benjamin Budish from Barclays set a target price of $101.0 on 07/10/2025
Patrick O'Shaughnessy from Raymond James set a target price of $96.0 on 07/09/2025
Alexander Blostein from Goldman Sachs set a target price of $97.0 on 07/02/2025
Owen Lau from Oppenheimer set a target price of $96.0 on 06/17/2025
Michael Cyprys from Morgan Stanley set a target price of $75.0 on 04/28/2025
Kyle Voigt from Keefe, Bruyette & Woods set a target price of $88.0 on 04/25/2025

Full Release

NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock and warrants of NKGen Biotech, Inc. NKGen Biotech, Inc.’s securities were suspended on March 5, 2025 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock, rights, and units of Aquaron Acquisition Corp. Aquaron Acquisition Corp.’s securities were suspended on March 7, 2025 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock, warrants, and rights of Bannix Acquisition Corp. Bannix Acquisition Corp.’s securities were suspended on March 17, 2025 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Avenue Therapeutics, Inc. Avenue Therapeutics, Inc.’s stock was suspended on March 19, 2025 and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock, warrants, units, and rights of WinVest Acquisition Corp. WinVest Acquisition Corp.’s securities were suspended on March 21, 2025 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of IMAC Holdings, Inc. IMAC Holdings, Inc.’s stock was suspended on March 26, 2025 and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common shares of Lytus Technologies Holdings PTV Ltd. Lytus Technologies Holdings PTV. Ltd.’s commons shares were suspended on March 31, 2025 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the ordinary shares of Luokung Technology Corp. Luokung Technology Corp’s security was suspended on March 31, 2025 and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common shares of Aptose Biosciences, Inc. Aptose Biosciences, Inc.’s common shares were suspended on April 2, 2025 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Virpax Pharmaceuticals, Inc. Virpax Pharmaceuticals, Inc.’s stock was suspended on April 4, 2025 and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the Class A ordinary shares, warrants, units, and rights of ClimateRock. ClimateRock’s securities were suspended on April 10, 2025 and have not traded on Nasdaq since that time.

The Nasdaq Stock Market announced today that it will delist the common stock of Phoenix Motor Inc. Phoenix Motor Inc.’s stock was suspended on April 15, 2025 and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the ordinary shares, units, and rights of AI TRANSPORTATION ACQUISITION CORP. AI TRANSPORTATION ACQUISITION CORP’s securities were suspended on April 16, 2025 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the Class A ordinary shares, warrants, and units of Denali Capital Acquisition Corp. Denali Capital Acquisition Corp.’s securities were suspended on April 16, 2025 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Thunder Power Holdings, Inc. Thunder Power Holdings, Inc.’s stock was suspended on April 22, 2025 and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Charles & Colvard Ltd. Charles & Colvard Ltd.’s stock was suspended on April 25, 2025 and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock, rights, units, and warrants of Yotta Acquisition Corporation. Yotta Acquisition Corporation’s securities were suspended on April 28, 2025 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the ordinary shares and warrants of Heramba Electric plc. Heramba Electric plc’s securities were suspended on April 29, 2025 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the Class A Common Stock of Cumulus Media Inc. Cumulus Media Inc.’s stock was suspended on May 2, 2025 and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the warrants, units, and subunits of Aimfinity Investment Corp I. Aimfinity Investment Corp. I’s securities were suspended on May 5, 2025 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the Class A ordinary shares of Starbox Group Holdings Ltd. Starbox Group Holdings Ltd.’s Class A ordinary shares were suspended on May 5, 2025 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock and warrants of Zoomcar Holdings, Inc. Zoomcar Holdings, Inc.’s securities were suspended on May 8, 2025 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of ConnectM Technology Solutions, Inc. ConnectM Technology Solutions, Inc.’s stock was suspended on May 8, 2025 and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the Class A ordinary shares, warrants, and units of Investcorp AI Acquisition Corp. Investcorp AI Acquisition Corp.’s securities were suspended on May 8, 2025 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the Class A ordinary shares, warrants, and units of Cartesian Growth Corporation II. Cartesian Growth Corporation II’s securities were suspended on May 13, 2025 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.’s stock was suspended on May 13, 2025 and has not traded on Nasdaq since that time

Nasdaq also announced today that it will delist the common stock of Accelerate Diagnostics, Inc. Accelerate Diagnostics, Inc.’s stock was suspended on May 15, 2025 and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Affimed NV. Affimed N.V.’s stock was suspended on May 20, 2025 and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock and warrants of AppTech Payments Corp. AppTech Payments Corp.’s securities were suspended on May 20, 2025 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Damon Inc. Damon Inc.’s stock was suspended on May 20, 2025 and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the ordinary shares and warrants of Zapp Electric Vehicles Group Limited. Zapp Electric Vehicles Group Limited’s securities were suspended on May 20, 2025 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common shares and warrants of LeddarTech Holdings Inc. LeddarTech Holdings Inc.’s securities were suspended on June 20, 2025 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Marin Software Incorporated. Marin Software Incorporated’s stock was suspended on June 26, 2025 and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock and warrants of Hall of Fame Resort & Entertainment Company. Hall of Fame Resort & Entertainment Company’s securities were suspended on June 27, 2025 and have not traded on Nasdaq since that time.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com. Nasdaq’s rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: https://listingcenter.nasdaq.com/rulebook/nasdaq/rules/nasdaq-5800-series .